Opinion|Videos|July 16, 2024
Differentiating Between the Semi-Fluorinated Alkane-Based Therapies for Dry Eye
Selina McGee, OD, FAAO, discusses the role of cyclosporine ophthalmic solution (VEVYE) in the treatment of dry eye disease.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- When do you prefer to use cyclosporine ophthalmic solution, 0.1% (VEVYE)? How are the indications for this drug different from perfluorohexyloctane ophthalmic solution?
Advertisement
Related to this article
Host Hamza Shah, OD, MS, FAAO, is joined by Cory Lappin, OD, MS, FAAO, to discuss dynamic muscle stimulation for dry eye, spurred by a paper on improving blinking in dry eye patients.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
More than monitoring: Using AMD visits to promote healthy vision aging
2
Brepocitinib for noninfectious uveitis meets all phase 3 trial end points
3
FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hours
4
BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial
5